malvidin has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Dong, J; Dong, Z; Fan, H; He, N; Liu, F; Yang, H; Zhang, W | 1 |
1 other study(ies) available for malvidin and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Malvidin protects against lipopolysaccharide-induced acute liver injury in mice via regulating Nrf2 and NLRP3 pathways and suppressing apoptosis and autophagy.
Topics: Animals; Anthocyanins; Antioxidants; Apoptosis; Autophagy; Catalase; Chemical and Drug Induced Liver Injury; Cytokines; Glutathione Peroxidase; Inflammasomes; Interleukin-6; Lipopolysaccharides; Male; Mice; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Protective Agents; RNA, Messenger; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |